|
|
 |
|
Biomarker discovery
|
|
|
Advancing biomarker discovery
In order to reduce the attrition rate in drug development, a global trend toward personalized medicine and companion diagnostics can be observed.
Key elements for these strategies are robust and validated biomarkers for predictive, prognostic and diagnostic purposes.
Miltenyi Biotec’s Genomic Service Team has gained substantial experience through the successful execution of several large-scale microarray projects carried out together with industrial and clinical partners, e.g., within different EU consortia, such as Indices of tolerance (IOT, Sagoo et al. 2010).
Because of this expertise, our Genomic Service Team is the ideal outsourcing partner for your biomarker research.
Use our contact form to get in touch and to discuss your projects with our experts.
|
|
|
|
|
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
|
